Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
Patients: A total of 9650 adult patients with established CV disease without CKD (56.7%), CKD only (13%), or both CV disease and CKD (27%) were randomized 1:1 to receive semaglutide tablets 14 mg (n=4825) or placebo (n=4825) once daily, both in addition to standard-of-care treatments for glycemic control and CV risk factors including blood pressure medication, lipid-lowering agents, and antiplatelet/anticoagulant therapy
Regularity matters
Faster visible results reinforce the behavioral changes needed to sustain long-term success
It's important to follow the dosing schedule your prescriber has given you and not to change your dose without consulting them
Does my insurance cover the recommended medication, and are there more affordable alternatives if coverage is an issue
Its generally safe to stop and restart semaglutide, but you should get your providers okay before making any changes
US$ 24.83
US$ 22.75
US$ 28.66
US$ 29.40
US$ 24.27
US$ 26.13
US$ 24.12
US$ 26.25
US$ 22.45
US$ 25.12
